LiquiVida Wellness Therapy Franchise For Sale
Liquivida® is the leader in the IV vitamin therapy industry and is fully diversified in its products and services. It serves customer needs ranging from anti-aging, medical aesthetics, and weight loss, along with personal beauty and care.
The US healthcare industry is broken. But we’re partnering with the best in modern medicine to make a difference in our communities and around the world. By focusing on the larger population, we believe we can proactively keep people healthy, so they can live more active and fulfilling lifestyles.
Why LiquVida?
· Proprietary Custom I.V. Drip Technology
· Multiple Revenue Streams: Products & Services
· Comprehensive Training & Ongoing Support
· Program Affiliated with Over 4000 Doctors
· No Medical License Required
· Membership model
· Multiple revenue streams
$ 398,000
Healthcare & Medical Businesses for Sale
Home Based Business Opportunities
Real Estate & Property Management Companies for Sale
Environmental Businesses for Sale
Grocery Stores & Delis for Sale
Smoke & Vape Shops for Sale
Convenience Stores & Lotto Businesses For Sale
Transport & Shipping Businesses for Sale
Gas Stations & Car Washes for Sale
Coffee Shop, Bakery & Dessert Businesses for Sale
Smoke & Vape Shop Franchises for Sale
Miscellaneous Franchises for Sale
Vending & Kiosk Franchises for Sale
Printing, Signs & Publishing Franchise Opportunities
Senior Care Franchise for Sale
Cleaning & Janitorial Franchises for Sale
Catering Franchise Opportunities
Entertainment & Recreation Franchise Opportunities
Environmental Franchise Opportunities
Real Estate & Property Management Franchise for Sale
Warehouses for Sale or Lease
Places of Worship for Sale
Medical Buildings for Sale or Lease
Retail Spaces for Lease or Sale
Office Spaces for Sale or Rent
Office Buildings for Sale or Rent
Plazas for Sale
Commercial Buildings for Sale or Lease
Mixed Use Buildings for Sale or Rent
Land & Developments for Sale
An email will be sent to registered email address.
Please select if you are: